1. Home
  2. RCKT vs PDCO Comparison

RCKT vs PDCO Comparison

Compare RCKT & PDCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PDCO
  • Stock Information
  • Founded
  • RCKT 1999
  • PDCO 1877
  • Country
  • RCKT United States
  • PDCO United States
  • Employees
  • RCKT N/A
  • PDCO N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PDCO Medical Specialities
  • Sector
  • RCKT Health Care
  • PDCO Health Care
  • Exchange
  • RCKT Nasdaq
  • PDCO Nasdaq
  • Market Cap
  • RCKT 1.6B
  • PDCO 1.9B
  • IPO Year
  • RCKT N/A
  • PDCO 1992
  • Fundamental
  • Price
  • RCKT $15.67
  • PDCO $20.00
  • Analyst Decision
  • RCKT Strong Buy
  • PDCO Hold
  • Analyst Count
  • RCKT 9
  • PDCO 8
  • Target Price
  • RCKT $53.22
  • PDCO $27.25
  • AVG Volume (30 Days)
  • RCKT 673.8K
  • PDCO 814.3K
  • Earning Date
  • RCKT 11-07-2024
  • PDCO 11-27-2024
  • Dividend Yield
  • RCKT N/A
  • PDCO 5.19%
  • EPS Growth
  • RCKT N/A
  • PDCO N/A
  • EPS
  • RCKT N/A
  • PDCO 1.83
  • Revenue
  • RCKT N/A
  • PDCO $6,533,269,000.00
  • Revenue This Year
  • RCKT N/A
  • PDCO $2.74
  • Revenue Next Year
  • RCKT $411.05
  • PDCO $3.25
  • P/E Ratio
  • RCKT N/A
  • PDCO $10.94
  • Revenue Growth
  • RCKT N/A
  • PDCO 0.13
  • 52 Week Low
  • RCKT $15.72
  • PDCO $19.89
  • 52 Week High
  • RCKT $32.53
  • PDCO $32.58
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 36.28
  • PDCO 38.29
  • Support Level
  • RCKT $16.65
  • PDCO $20.62
  • Resistance Level
  • RCKT $17.83
  • PDCO $21.26
  • Average True Range (ATR)
  • RCKT 0.80
  • PDCO 0.62
  • MACD
  • RCKT -0.09
  • PDCO -0.07
  • Stochastic Oscillator
  • RCKT 0.79
  • PDCO 1.25

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About PDCO Patterson Companies Inc.

Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.

Share on Social Networks: